1. Gu, Yu, Xu, Zi-Jun, Zhou, Jing-Dong, Lin, Jiang, Qian, Jun. 2022. SLC22A3 methylation-mediated gene silencing predicts adverse prognosis in acute myeloid leukemia. In Clinical epigenetics, 14, 162. doi:10.1186/s13148-022-01373-w. https://pubmed.ncbi.nlm.nih.gov/36461046/
2. Zheng, Peng-Fei, Yin, Rui-Xing, Cao, Xiao-Li, Wei, Bi-Liu, Liu, Chun-Xiao. 2021. SYTL3-SLC22A3 Single-Nucleotide Polymorphisms and Gene-Gene/Environment Interactions on the Risk of Hyperlipidemia. In Frontiers in genetics, 12, 679027. doi:10.3389/fgene.2021.679027. https://pubmed.ncbi.nlm.nih.gov/34367243/
3. Xiong, Ji-Xian, Wang, Yan-Song, Sheng, Jingyi, Guan, Xin-Yuan, Fu, Li. 2018. Epigenetic alterations of a novel antioxidant gene SLC22A3 predispose susceptible individuals to increased risk of esophageal cancer. In International journal of biological sciences, 14, 1658-1668. doi:10.7150/ijbs.28482. https://pubmed.ncbi.nlm.nih.gov/30416380/
4. Wang, Long, Chen, Juan, Zeng, Ying, Wu, Tangchun, Zhou, Li. 2016. Functional Variant in the SLC22A3-LPAL2-LPA Gene Cluster Contributes to the Severity of Coronary Artery Disease. In Arteriosclerosis, thrombosis, and vascular biology, 36, 1989-96. doi:10.1161/ATVBAHA.116.307311. https://pubmed.ncbi.nlm.nih.gov/27417586/
5. Nguyen, Thuy-An, Le, Minh-Khang, Nguyen, Phuc-Tan, Kondo, Tetsuo, Nakao, Atsuhito. 2023. SLC22A3 that encodes organic cation transporter-3 is associated with prognosis and immunogenicity of human lung squamous cell carcinoma. In Translational lung cancer research, 12, 1972-1986. doi:10.21037/tlcr-23-334. https://pubmed.ncbi.nlm.nih.gov/38025816/
智鼠故事 
